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Edited by Irmgard SinningAbstract Human islet amyloid polypeptide (hIAPP) forms
amyloid deposits in non-insulin-dependent diabetes mellitus
(NIDDM). Pre-ﬁbrillar hIAPP oligomers (in contrast to mono-
meric IAPP or mature ﬁbrils) increase membrane permeability,
suggesting an important role in the disease. In the ﬁrst structural
study of membrane-associated hIAPP, lamellar neutron diﬀrac-
tion shows that oligomeric hIAPP inserts into phospholipid
bilayers, and extends across the membrane. Rifampicin, which
inhibits hIAPP-induced membrane permeabilisation in functional
studies, prevents membrane insertion. In contrast, rat IAPP
(84% identical to hIAPP, but non-amyloidogenic) does not insert
into bilayers. Our ﬁndings are consistent with the hypothesis that
membrane-active pre-ﬁbrillar hIAPP oligomers insert into beta
cell membranes in NIDDM.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A number of extracellular proteins can misfold spontane-
ously and aggregate to form b-sheet rich amyloid deposits
characteristic of a variety of ‘‘protein misfolding’’ diseases,
most notably Alzheimers disease [1,2]. While the precise
molecular basis of such conditions is unclear, strong argu-
ments are emerging to implicate organ-speciﬁc amyloidogenic
proteins, particularly oligomeric intermediates on the pathway
to amyloid ﬁbril formation, in disease pathogenesis (e.g. [3]).
Human islet amyloid polypeptide (hIAPP), a 37-residue pep-
tide hormone secreted by pancreatic beta cells, often forms
amyloid deposits in patients aﬀected by NIDDM (non-insulin
dependent or type 2, maturity onset, diabetes mellitus). We re-
cently demonstrated that an intermediate, non-ﬁbrillar, oligo-
meric form of hIAPP interacts with membranes, whereas
ﬁbrillar hIAPP (like normal, monomeric hIAPP) lacks mem-
brane activity [4]. Interestingly, the membrane activity of
hIAPP could be inhibited independently of its ability to form
amyloid [5]. These Langmuir balance measurements provided
a further test of the idea that only the pre-ﬁbrillar, oligomeric*Corresponding author. Fax: +44 131 650 6139.
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ert. Oligomeric intermediates in the misfolding process may
form non-speciﬁc cation channels [6], and cellular Ca2+-over-
load could account for the toxicity of hIAPP [7], and explain
why exposed cells die by both apoptosis and necrosis [4].
Unlike hIAPP, rat IAPP (rIAPP) is inert [4]. Sequence vari-
ations in IAPP are strongly associated with the ability of the
peptide to form amyloid, and susceptibility to NIDDM [8,9].
Human and cat IAPP contain the internal sequence NFGAIL
(Fig. 1), and both species can form islet amyloid and develop
NIDDM. The rat and mouse genes do not encode this motif,
and these species do not exhibit islet amyloid or NIDDM.
However, mice expressing the hIAPP transgene do develop a
NIDDM-like disease [10].
The membrane-active form of hIAPP is currently poorly de-
ﬁned. In the present study, we identiﬁed the membrane-associ-
ated form of hIAPP in stacked phospholipid bilayers using
neutron diﬀraction. In order to mimic, as closely as possible,
the experimental conditions of our previous studies [4,5] the
lipid system for this work was a 50:50 mixture of palmitoyl-
oleoyl phosphatidylethanolamine (POPE) and palmitoyl-
oleoyl phosphatidylserine (POPS). We directly tested the
hypothesis that hIAPP oligomers span the bilayer, and our
ﬁndings are consistent with the idea that oligomeric hIAPP
is associated with the formation of transmembrane channels.
rIAPP was excluded from the membrane, as predicted, and rif-
ampicin, an inhibitor of the membrane activity of hIAPP [5],
prevents membrane insertion.2. Materials and methods
2.1. Materials
hIAPP and rIAPP were obtained from Bachem (Weil am Rhein,
Germany). POPE and POPS were purchased from Avanti Polar Lipids
(Birmingham, AL) and rifampicin was from Fluka (Poole, UK). Other
chemicals were of the highest purity available.
2.2. Sample preparation and data collection
Multibilayer stacks of phospholipids and peptides were prepared as
described previously [11]. Brieﬂy, 20 mg of a 50:50 (mol) mixture of
POPE and POPS were co-dissolved with 1% (mol) peptide in chloro-
form:triﬂuoroethanol (7:3, v/v) and airbrushed onto a quartz glass
slide to produce highly aligned stacks of some 50 000 or so bilayers.
Where rifampicin was required in a sample, this was added to the lipid
mixture before the peptide. The wafers were placed under vacuum for
24 h to remove the solvents before being mounted in sealed sample
cans and hydrated for 12 h at 25 C to allow full equilibration and
the formation of IAPP oligomers [4,5]. The sample cans containedblished by Elsevier B.V. All rights reserved.
Fig. 1. Hydrophobicity plot of hIAPP (Swiss-Prot P10997) and rIAPP
(Swiss-Prot P12969), using the whole residue hydrophobicity scale of
Wimley and White [25]. The inset shows a sequence alignment of the
two peptides. Each peptide has a disulﬁde-bridged loop at its N-
terminal end. The NFGAIL motif, present in species susceptible to
islet amyloid and NIDDM, is underlined. The three prolines present in
rat but not hIAPP are indicated in bold.
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2H2O/H2O mixtures
to maintain a relative humidity of 85%, 92% or 97%, respectively,
and the 2H2O concentration was set to 8% (v/v) in the presence of each
of the three salts, and also to 20% (v/v) and 50% (v/v) in K2NO3 alone.
Diﬀraction data sets, comprising ﬁve orders of diﬀraction, were col-
lected for each of the ﬁve conditions on V1 at the Berlin Neutron-Scat-
tering Center, Hahn-Meitner-Institut, Berlin, Germany, by scanning
samples through ±2 around the predicted Bragg angle for each of
the ﬁrst ﬁve orders of diﬀraction in turn.
2.3. Data analysis
After background subtraction, peak ﬁtting and absorption and
Lorentz corrections, the intensities were square-rooted to provide
structure factor amplitudes. Phasing the structure factors is a two
stage process. In the ﬁrst, the three sets of 8% 2H2O structure factors
are ﬁtted to a single continuous transform, thereby ﬁxing their
phases [11]. In the second, the 8% 2H2O phases are used as a basis
for phasing the data collected at 20% and 50% 2H2O by least-
squares ﬁtting to straight line functions, as described previously
[12]. This two-step approach has the added advantage that an accu-
rate set of 8% 2H2O structure factors can be calculated from ﬁrst
stage for increased accuracy in the second. The data were then
placed on a relative absolute scale using the method of White
and co-workers [13]. In this approach, the data are placed on an
absolute scale using the known neutron scattering lengths of all com-
ponent molecules. However, since the x and y dimensions are not
probed by lamellar diﬀraction methods, these two dimensions are
not speciﬁed in the treatment of the data. The structure factor data,
and the proﬁles calculated from them are, therefore, scaled to repre-
sent a single pair of lipids plus the appropriate number of water and
peptide molecules. At 1% (mol) peptide, the unit cell in this study
represents two lipid molecules and 0.02 molecules of peptide.3. Results
3.1. Lamellar d-repeats
The lamellar spacings (d-repeats)of the samplesat92%relative
humidity were determined by optimised least squares ﬁtting to
ﬁve orders of diﬀraction. 1% (mol) hIAPPdecreased the lamellar
spacing signiﬁcantly from 62.09 ± 0.16 A˚ (means ± S.D., n = 3)to 61.51 ± 0.20 A˚ (means + S.D., n = 3, P < 0.02 by t-testing),
while rIAPP increased the spacing slightly to 62.72 ± 0.57 A˚
(n = 3, P > 0.05). The measurements for phospholipids with 1%
(mol) rifampicin were 56.96 ± 0.43 A˚ (means ± S.D., n = 3),
and forphospholipidswith 1% (mol) hIAPPand1%(mol) rifam-
picin, 58.53 ± 0.27 A˚ (means ± S.D., n = 3). The diﬀerence in
d-repeats between bilayers containing hIAPP and rIAPP (in the
absence of rifampicin) is 1.2 A˚.Assuming an average bilayer sur-
faceareaof 72 A˚2perphospholipid [14], this diﬀerence equates to
a volume increase of 87 A˚3 per pair of lipids (the basis of the rel-
ative absolute scaling method). The total molecular volume of
IAPPcalculatedfromaminoacidvolumes in theIMBJenaImage
Library (http://www.imb-jena.de) is 4680 A˚3. At 1% (mol), this
equates to an extra volume of 47 A˚3 per lipid, or 94 A˚3 per pair
of lipids.
The additional volume of the peptide could be accommo-
dated either by expansion of the unit cell in the Z-direction
(e.g., if the long axis of the peptide lies parallel to the bilayer),
or by insertion of hIAPP between the bilayer phospholipids, or
both. The signiﬁcant decrease in the d-repeat in the presence of
hIAPP was inconsistent with the ﬁrst possibility. However,
expansion of the unit cell in the plane of the bilayer, the second
possibility, is invisible to lamellar diﬀraction methods, and is
not constrained in the relative absolute method used in this
study. Moreover, the idea that the peptide inserted into the bi-
layer was consistent with the monolayer expansion seen in pre-
vious Langmuir balance measurements using the same lipids
[5]. We therefore investigated the possible membrane insertion
of hIAPP in more detail, by examining bilayer scattering
proﬁles.
3.2. Bilayer proﬁles
The neutron scattering length density proﬁle of POPE/POPS
bilayers in the absence of peptide (Fig. 2(a)) diﬀers from the
‘‘standard’’ proﬁle of dioleoylphosphatidylcholine (DOPC)
[11], most noticeably because the dip in scattering length density
seen in thewater region ofDOPCbilayer proﬁles is barely visible
in the POPE/POPS proﬁle. This can be explained by the diﬀerent
neutron scattering lengths of the phospholipid headgroups. The
total scattering length of the PC (C5H13N), PE (C2H7N) and PS
(C3H6O2N) headgroups are 0.60 · 1013 cm, 0.597 · 1013
cmand 1.85 · 1013 cm, respectively.When two sodiumcounter
ions are added to the PS headgroup (0.72 · 1013 cm), the extra
density in the mixed lipid bilayers is readily explained.
The bilayer proﬁle in the presence of hIAPP (Fig. 2(b)) was
remarkably similar to that of pure lipid bilayers. The total neu-
tron scattering length per peptide molecule is 98.78 · 1012 cm
(hIAPP) or 98.51 · 1012 cm (rIAPP). The water region was
almost indistinguishable from the pure phospholipid bilayer,
and any relatively slight diﬀerences were largely conﬁned to
an increase in density in the fatty-acyl region. rIAPP, on the
other hand, caused major changes to the water region (Fig.
2(c)). The characteristic minimum at the edges of the proﬁle
were completely absent, suggesting that the additional neutron
scattering length density introduced by the peptide now ﬁlled
this trough. The proﬁle shape changes in the fatty acyl-region
were consistent with lipid rearrangements rather than peptide
penetration. A peptide orientated parallel to the bilayer is
likely to cause greater fatty-acyl disruption than a transbilayer
peptide, for two reasons: (i) the parallel peptide will have con-
tacts with a much larger number of phospholipids than a trans-
bilayer peptide and (ii) the parallel peptide only occupies part
Fig. 2. Neutron scattering length density proﬁles of phospholipid
bilayers: (a) 50:50 (mol) mixture of POPE and POPS; (b) 50:50 (mol)
mixture of POPE and POPS with 1% (mol) hIAPP; (c) 50:50 (mol)
mixture of POPE and POPS with 1% (mol) rIAPP; (d) 50:50
(mol) mixture of POPE and POPS with 1% (mol) rifampicin; (e)
50:50 (mol) mixture of POPE and POPS with 1% (mol) hIAPP and 1%
(mol) rifampicin hIAPP. The structure factors for bilayers hydrated
with 8% 2H2O were used to calculate the proﬁles, since water of this
isotopic composition has a net neutron scattering length density of
zero. The proﬁles have been displaced vertically, for clarity. A pair of
lipid molecules is also shown, for orientation.
Fig. 3. Top: the structure of rifampicin. Bottom: Cartoon showing
possible mechanism of bilayer thinning (arrow) when (a) a peptide
inserts parallel to the bilayer surface or (b) rifampicin inserts close to
the terminal methyl groups. For explanation, see text.
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that has to be ﬁlled by the fatty-acyl chains of the surrounding
lipids (Fig. 3(a)). A similar eﬀect has been observed in another
interfacial peptide, the antimicrobial peptide protegrin-1 [15].
An alternative mechanism of bilayer thinning is based on the
observation that an incorporated molecule may alter the ther-
mal ﬂuctuations which, in turn, can aﬀect the inter-bilayer dis-
tance [16].
Taken together, these proﬁles show clear diﬀerences in the
relationship of the two peptides with the lipid bilayer. rIAPP
appears to reside exclusively in the water layer between the
bilayers, whereas hIAPP is largely excluded from this region.
This conclusion is further supported by the observation (Figs.
2(a) and (c)) that the bilayers are thinner in the presence of
rIAPP, despite the overall increase in d-repeat. In proﬁle (a),
the two maxima in the neutron scattering length density are
caused by strong neutron scattering by the phosphates andthe oxygen rich (and hydrogen-poor) ester linkages of the
phospholipids. Although partially obscured by scattering from
the peptide, the steep gradients up towards the corresponding
region are closer together in proﬁle (c) compared to (a).
We next examined how the inhibitor rifampicin interacted
with phospholipid bilayers in the absence of peptide. The total
neutron scattering length per rifampicin molecule is
18.67 · 1012 cm. Previous studies of rifampicin partitioning
using derivative spectrophotometry [17] and 1H NMR and
ﬂuorescence energy transfer [18] suggested that the compound
inserts deeply into the hydrophobic core of the bilayer, while
remaining in contact with the polar surface. With a pKa of
7.9, rifampicin has partial anionic character at neutral pH,
and this has been correlated with a stronger interaction with
zwitterionic lipids such as di-myristoyl phosphatidylcholine
(Kd = 5.09 · 104) compared to anionic lipids such as di-myri-
stoyl phosphatidylglycerol (Kd = 0.54 · 104) [18]. While in
broad agreement that rifampicin forms stable bilayers with an-
ionic or zwitterionic lipids, our neutron data reveal that rifam-
picin induces marked structural changes in the membrane (the
NMR technique used by Rodrigues [18] is blind to the details
of bilayer structure revealed by neutron diﬀraction).
In particular, the bilayer proﬁles in Figs. 2(a) and (d) show
diﬀerences in bilayer width, as revealed by the distance be-
tween the two maxima, and the bilayer thinning caused by rif-
ampicin is reﬂected in the reduced d-repeat of the
corresponding samples. These eﬀects may be explained by
‘‘splaying’’ of the phospholipid headgroup regions over the
top of deeply inserted rifampicin (Fig. 3(b)). Rodrigues also
positions rifampicin close to the terminal methyls of the
fatty-acyl chains [18], consistent with our observation that
the methyl trough is broadened, as revealed by the neutron
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of hIAPP to the bilayers in the presence of rifampicin thins the
bilayer even further, yet increases the d-repeat by 1.5 A˚. Both
of these observations are consistent with location of the pep-
tide to the water/bilayer interfacial region, strongly implying
that rifampicin has prevented transbilayer insertion of the
peptide.
3.3. The distribution of water
Water distribution proﬁles were calculated by Fourier
transformations of diﬀerence structure factor proﬁles ob-
tained by least-squares ﬁtting to 8%, 20% and 50% 2H2O
sample hydrations. The water proﬁle for pure lipid bilayers,
shown in Fig. 4(a), was entirely consistent with previous neu-
tron studies of phospholipid membranes. The single peak
(split between the two ends of the proﬁle in the ﬁgure) repre-
sents a block of water conﬁned between adjacent bilayers inFig. 4. Diﬀerence proﬁles of the neutron scattering length density of
water (2H2O) in stacked phospholipid bilayers: (a) 50:50 (mol) mixture
of POPE and POPS; (b) 50:50 (mol) mixture of POPE and POPS with
1% (mol) hIAPP; (c) 50:50 (mol) mixture of POPE and POPS with 1%
(mol) rIAPP; (d) 50:50 (mol) mixture of POPE and POPS with
1% (mol) rifampicin; (e) 50:50 (mol) mixture of POPE and POPS with
1% (mol) hIAPP and 1% (mol) rifampicin hIAPP. Structure factors for
bilayers hydrated in 100% H2O were subtracted from corresponding
50% 2H2O structure factors and the result used to calculate the proﬁles
shown. The proﬁles have been displaced vertically, for clarity.the multi-bilayer stack. The peak can be ﬁtted (in reciprocal
space) to a single pair of Gaussians, centred at 27.8(6) A˚
from the middle of the bilayer and 5.8(2) A˚ wide (full width
at 1/e height).
The corresponding water distribution proﬁle for bilayers
containing 1% (mol) rIAPP (Fig. 4(c)) was similar. Once
again, the water was conﬁned to the outer sections of the
proﬁle, representing the inter-bilayer hydration layer. This
block of neutron scattering length density was ﬁtted (in reci-
procal space) to a pair of Gaussians, centred 27.1(1) A˚ from
the middle of the bilayer, and 4.2(5) A˚ wide. However, in the
IAPP proﬁles (Fig. 4(b)), the same amount of water was dis-
tributed very diﬀerently. Instead of being conﬁned to the
edges, it extended across the entire width of the repeating
unit, including the phospholipid bilayer itself. The area under
the central portion of this curve corresponds to around 500
deuterons per peptide, comprising water and exchanged pro-
tons. This indicates the presence of channel-structures,
though the neutron data do not supply any information on
the number of peptides per channel. This observation sup-
ports the proposal that hIAPP, but not rIAPP, inserts in a
transbilayer orientation in the phospholipid bilayers used in
this study.
In contrast, in POPC/POPS bilayers with 1% (mol) rifampi-
cin (Fig. 4(d)), the water was largely conﬁned to the inter-
bilayer region, and as previously noted, the lipid proﬁle diﬀered
in shape (cf. Fig. 4(a)). This conﬁrms the suggestion that rifam-
picin and phospholipids form stable bilayers, but refutes the
claim [18] that the bilayer structure remains unchanged. Of
particular interest is the observation that the addition of rifam-
picin to bilayers containing hIAPP (Fig. 4(e)) constrained the
deuterons to the inter-bilayer region, in contrast to appear-
ances in the absence of rifampicin (Fig. 4(b)). However, it is
known from functional studies that rifampicin prevents bilayer
insertion of hIAPP, rather than blocking pre-inserted ‘‘chan-
nels’’ [5].4. Discussion
In the absence of high-resolution structural data, we have
speculated that membrane-active IAPP is a misfolded, b-
sheet-rich, primary nucleation element on the amyloid path-
way that can insert spontaneously into membranes [5].
Membrane-located IAPP may then refold to give rise to trans-
membrane a-helices surrounding a central ion channel or pore
[5,6]. In this respect, IAPP may follow the pattern displayed by
calcitonin (CT), an amyloid-forming peptide that has previ-
ously been studied in detail. CT is a 32-amino acid polypeptide
hormone that shows sequence and charge distribution similar-
ities to IAPP and can adopt either a- or b-structures, depend-
ing on its environment. The former is seen in phospholipid
membranes [19], while the latter predominates in aqueous solu-
tion [20]. Using methods similar to those in the present study,
Bradshaw [19] showed that salmon CT could insert into
phospholipid bilayers containing the anionic lipid phosphati-
dylglycerol, leading to speculation that the peptide may have
ion-channel properties. This was later conﬁrmed by Stipani
et al. [21]. Human CT formed channels at the same concentra-
tion, but not as easily as salmon CT, an observation the
authors attributed to the reduced helical content of this form
of the peptide.
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tron experiment, the amyloid-forming proteins may form ﬁ-
brils. However, the neutron data describe highly ordered
systems, that do not change over the duration of the neutron
measurements. This is consistent with our previous lipid
bilayer work [4] and Langmuir balance work [5] that demon-
strated that the mature ﬁbril for of IAPP is not membrane-
active. Furthermore, it is simply not known whether ﬁbrils
can form from peptide that has already inserted into a mem-
brane. The transconformational changes involved in morphing
from a structure optimised for a hydrophobic membrane envi-
ronment to the cross-b amyloid structure could be consider-
ably greater than those involved in adopting the amyloid
conformation from aqueous solution.
Fig. 1 shows a hydrophobicity plot for the two peptides.
rIAPP is clearly less hydrophobic than hAIPP, a fact which
may contribute to the latters inability to insert into phospho-
lipid bilayers. However, peptide insertion into bilayers also
requires the formation of secondary structure and the se-
quence diﬀerences between the two forms of IAPP will have
a signiﬁcant eﬀect on rIAPPs ability to form this structure.
The main diﬀerences between the sequences of hIAPP and
rIAPP are the replacement of the alanine at position 35,
and the serines at positions 38 and 39, with proline residues.
The ﬁrst of these replacements disrupts the NFGAIL se-
quence linked to the formation of islet amyloid and suscepti-
bility to NIDDM [8,9]. Proline is a well-established
‘‘breaker’’ of both a-helix and b-sheet structures in globular
proteins, because the closed loop structure of the side chain
prevents the peptide backbone from adopting the u and w
angles required for either of these secondary structures. How-
ever, proline frequently occurs in the transmembrane helices
of integral membrane proteins, particularly transport pro-
teins, despite the fact that a kink is introduced wherever a
proline residue interrupts a helical section. Li and Derber
[22] resolved this apparent contradiction by postulating diﬀer-
ent rules governing structure in the hydrophobic environment
of membranes, and showed that the helical propensity of pro-
line was greatly enhanced in the membrane-mimetic environ-
ments of both lipid micelles and organic solvents. In studies
of a proline to alanine replacement in a single-spanning mem-
brane protein of bacteriophage IKe, Li and Derber [22]
showed that proline does not interfere with helix formation,
but does prevent the formation of b-sheet. The intrinsic
capacity of proline to disrupt b-structures has also been dem-
onstrated by showing that prolines are excluded from trans-
membrane b-strands in mutagenised OmpA porins that
retain the ability to assemble into a membrane-spanning b-
barrel [23]. Wigley et al. [24] has proposed that the abun-
dance of proline in transmembrane helices can be entirely
explained by the ability of the residue to block b-structures.
The advantage conferred by preventing the formation of
a b-sheet outweighs the entropic disadvantage in helix
distortion.
In this context, it is instructive to consider the diﬀerences in
sequence, amyloidogenicity and membrane-associated neutron
scattering proﬁles of hIAPP and rIAPP. Following the argu-
ments outlined above, it is tempting to suggest that rIAPP is
non-amyloidogenic because the introduction of a proline into
the NFGAIL sequence prevents the peptide from adopting
the b-structure necessary for amyloid ﬁbre formation. How-
ever, this should not signiﬁcantly interfere with the peptidesability to insert into phospholipid membranes, if the mem-
brane-active form is a-helical (like the model for CT). Previous
studies, and our current neutron diﬀraction data, indicate that
this is not so. Rats are not susceptible to ‘‘NIDDM’’, and the
neutron data suggest that rIAPP does not insert into phospho-
lipid membranes.
This could be taken as evidence that the membrane-active
form of hIAPP is not a-helical, until it is remembered that
rIAPP possesses not one but three extra prolines. The disrup-
tive eﬀect of three prolines in close proximity (two of them
consecutive residues) is likely to block the formation of both
a- and b-structures by the peptide. In the future work, it will
clearly be of interest to probe the secondary, tertiary and qua-
ternary structure of membrane-associated hIAPP in detail.
In conclusion, our data represent the ﬁrst study of mem-
brane-associated IAPP to use diﬀraction-based techniques.
We have shown that oligomeric hIAPP interacts with
phospholipid membranes to form transbilayer structures.
rIAPP is excluded from the membrane (as predicted), and
the insertion of hIAPP is inhibited by rifampicin.
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